21 Finance Monthly Deal Maker Awards 2023 Germany or scientist, but I think it is also key to our work as lawyers. Deal counsel have the opportunity to witness such incredibly exciting and innovative developments. We bring our expertise to the table – and yet we are only a small component in the whole. I like to completely immerse myself and learn as much as I can about the client and the technology before I really start advising. What does this award mean to you? I am extremely pleased to receive this award. Of course, my team and I are grateful for the accolade. But I also see the award as recognition for a subject that (unfortunately) still leads a bit of a shadowy existence: licensing and collaborations in life sciences. It would be great if this award can contribute a little bit to making this subject better known. Is there any advice that you would give to prospective IP and IT lawyers looking to emulate your success? I would advise prospective IP and IT colleagues to look at our subject holistically. Do not focus too early on only one (small) specialist subject within the broad field of IP/IT, but recognise the many similarities and repetitions, regardless of whether you are working in patent law, (software) copyright or trade secret protection. For all those who work outside the subject of IP/IT, our field is a special matter anyway. What are your current plans for 2023? Earlier this year we expanded my team – we are now five lawyers focused on advising on life sciences transactions and commercial work. In 2023, we will continue to pursue this focus; we will continue to grow our client base (including in academia) and we may soon have the opportunity to be involved in some truly pioneering collaborations again.
RkJQdWJsaXNoZXIy Mjk3Mzkz